216 related articles for article (PubMed ID: 33938570)
1. Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
Li S; He Z; Mo C; Ji Y; Luo Y; Fang Q; Gao Y
Transfusion; 2021 Jun; 61(6):1908-1915. PubMed ID: 33938570
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietic suppression in fetal anemia because of Kell alloimmunization.
Vaughan JI; Warwick R; Letsky E; Nicolini U; Rodeck CH; Fisk NM
Am J Obstet Gynecol; 1994 Jul; 171(1):247-52. PubMed ID: 8030708
[TBL] [Abstract][Full Text] [Related]
3. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
[TBL] [Abstract][Full Text] [Related]
4. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia.
Weiner CP; Widness JA
Am J Obstet Gynecol; 1996 Feb; 174(2):547-51. PubMed ID: 8623782
[TBL] [Abstract][Full Text] [Related]
5. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.
Yasuda H; Ohto H; Nollet KE; Kawabata K; Saito S; Yagi Y; Negishi Y; Ishida A
Transfus Med Rev; 2014 Jan; 28(1):1-6. PubMed ID: 24262303
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature.
Li S; Mo C; Huang L; Shi X; Luo G; Ji Y; Fang Q
Transfusion; 2019 Jan; 59(1):385-395. PubMed ID: 30520533
[TBL] [Abstract][Full Text] [Related]
8. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
Blyth U; Larsson M; Baird A; Waring G; Athiraman N
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.
Delaney M; Matthews DC
Hematology Am Soc Hematol Educ Program; 2015; 2015():146-51. PubMed ID: 26637714
[TBL] [Abstract][Full Text] [Related]
10. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.
Thorp JA; O'Connor T; Callenbach J; Cohen GR; Yeast JD; Albin J; Plapp F
Am J Obstet Gynecol; 1991 Jul; 165(1):79-81. PubMed ID: 1853921
[TBL] [Abstract][Full Text] [Related]
11. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
Pessler F; Hart D
J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
Andersen LH; Jacob EK; McThenia SS; Tauscher CD; Patterson ER; Oliveira JL; Rodriguez V
Transfusion; 2021 Mar; 61(3):974-978. PubMed ID: 33444461
[TBL] [Abstract][Full Text] [Related]
13. Effect of Anti-D titers in RhD-negative pregnant women on fetuses and newborns: A retrospective study.
Tang TH; Guo CY; Li XY; Hu YX; Liu WK; Yu MX
Pediatr Neonatol; 2024 May; 65(3):288-292. PubMed ID: 37957047
[TBL] [Abstract][Full Text] [Related]
14. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
15. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
16. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
17. Anemic Disease of the Newborn With Little Increase in Hemolysis and Erythropoiesis Due to Maternal Anti-Jr
Katsuragi S; Ohto H; Yoshida A; Otake A; Tsuneyama H; Ogasawara K; Isa K; Ikeda T
Transfus Med Rev; 2019 Jul; 33(3):183-188. PubMed ID: 31227265
[TBL] [Abstract][Full Text] [Related]
18. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
19. Persistence of Villous Immaturity in Term Deliveries Following Intrauterine Transfusion for Parvovirus B19 Infection and RhD-associated Hemolytic Disease of the Fetus and Newborn.
McCarthy WA; Popek EJ
Pediatr Dev Pathol; 2017; 20(6):469-474. PubMed ID: 29187036
[TBL] [Abstract][Full Text] [Related]
20. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
Roubalová L; Lubušký M
Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
